Niramai Health Analytix Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 24-05-2024
- Paid Up Capital ₹ 1.17 M
as on 24-05-2024
- Company Age 8 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 10.00 Cr
as on 24-05-2024
- Revenue 63.94%
(FY 2023)
- Profit -4.24%
(FY 2023)
- Ebitda -11.57%
(FY 2023)
- Net Worth -35.50%
(FY 2023)
- Total Assets -32.35%
(FY 2023)
About Niramai Health Analytix
The Company is engaged in the Information Technology Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.17 M.
The company has closed loans amounting to ₹10.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Himanshu Madhu, Geetha Manjunath, Munehiko Eto, and One other member serve as directors at the Company.
- CIN/LLPIN
U72200KA2016PTC095020
- Company No.
095020
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Jul 2016
- Date of AGM
14 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Niramai Health Analytix Private Limited offer?
Niramai Health Analytix Private Limited offers a wide range of products and services, including Medical Treatment Services, Breast Cancer Treatment, Thermal Scanner & Camera.
Who are the key members and board of directors at Niramai Health Analytix?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Geetha Manjunath  | Managing Director | 14-Jul-2016 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Munehiko Eto  | Nominee Director | 15-Mar-2019 | Current |
| Manish Singhal | Nominee Director | 24-Jan-2019 | Current |
| Himanshu Madhu | Director | 26-Apr-2022 | Current |
Financial Performance and Corporate Structure Insights of Niramai Health Analytix.
Niramai Health Analytix Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 63.94% increase. The company also saw a slight decrease in profitability, with a 4.24% decrease in profit. The company's net worth observed a substantial decline by a decrease of 35.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Niramai Health Analytix?
In 2023, Niramai Health Analytix had a public holding of 42.97%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Nov 2020 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Niramai Health Analytix?
Niramai Health Analytix has a workforce of 51 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Niramai Health Analytix, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Niramai Health Analytix's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
